large-scale 3d reconstruction engine recap photo Search Results


large scale huygens  (Photonics Inc)
86
Photonics Inc large scale huygens
Large Scale Huygens, supplied by Photonics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/large-scale+3d+reconstruction+engine+recap+photo/pm41366244-379-7-16?v=Photonics+Inc
Average 86 stars, based on 1 article reviews
large scale huygens - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
large scale endosomal rupture recruits galectins  (Galectin Therapeutics)
86
Galectin Therapeutics large scale endosomal rupture recruits galectins
The optimization strategies for enhancing LNP targeting and <t>endosomal</t> escape are summarized as follows: panel (A) illustrates organ‐selective delivery profiles of various LNP formulations. Conventional ionizable lipids with p K a values ranging from 6.2 to 6.5 (e.g., DLin‐DMA, MC3, SM‐102, ALC‐0315, and 113‐O12B) exhibit liver tropism. Permanently ionizable lipids (e.g., DOTAP, DDAB, EPC, and 306‐N16B) favor lung targeting, while anionic lipids (e.g., 18PA, 14PA, and 18BMP) and polymer modifications (e.g., APEs and Pi‐A10) are associated with spleen accumulation. Panel (B) depicts key mechanisms of endosomal escape that enhance both CD4⁺ and CD8⁺ T cell responses. Strategies include conjugating LNPs with antibodies or PEI polymers, inhibiting the interaction between LNPs and ANXA6, and employing ionizable lipids with unsaturated hydrophobic tails, which significantly improve endosomal escape efficiency and thereby enhance antigen expression and immune activation. Panel (C) shows that LNPs can bind to ApoE, which facilitates recognition by LDLRs on hepatic endothelial cells, contributing to hepatic accumulation—a typical feature of traditional LNPs. Panel (D) outlines injection sites for different administration routes (intramuscular, subcutaneous, intravenous, and intradermal), which influence how LNP‐based vaccines enter the body and determine the type and strength of immune responses elicited (created in https://BioRender.com ).
Large Scale Endosomal Rupture Recruits Galectins, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/large-scale+3d+reconstruction+engine+recap+photo/pmc12497691-766-0-6?v=Galectin+Therapeutics
Average 86 stars, based on 1 article reviews
large scale endosomal rupture recruits galectins - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
mammography equipment  (Siemens AG)
90
Siemens AG mammography equipment
The optimization strategies for enhancing LNP targeting and <t>endosomal</t> escape are summarized as follows: panel (A) illustrates organ‐selective delivery profiles of various LNP formulations. Conventional ionizable lipids with p K a values ranging from 6.2 to 6.5 (e.g., DLin‐DMA, MC3, SM‐102, ALC‐0315, and 113‐O12B) exhibit liver tropism. Permanently ionizable lipids (e.g., DOTAP, DDAB, EPC, and 306‐N16B) favor lung targeting, while anionic lipids (e.g., 18PA, 14PA, and 18BMP) and polymer modifications (e.g., APEs and Pi‐A10) are associated with spleen accumulation. Panel (B) depicts key mechanisms of endosomal escape that enhance both CD4⁺ and CD8⁺ T cell responses. Strategies include conjugating LNPs with antibodies or PEI polymers, inhibiting the interaction between LNPs and ANXA6, and employing ionizable lipids with unsaturated hydrophobic tails, which significantly improve endosomal escape efficiency and thereby enhance antigen expression and immune activation. Panel (C) shows that LNPs can bind to ApoE, which facilitates recognition by LDLRs on hepatic endothelial cells, contributing to hepatic accumulation—a typical feature of traditional LNPs. Panel (D) outlines injection sites for different administration routes (intramuscular, subcutaneous, intravenous, and intradermal), which influence how LNP‐based vaccines enter the body and determine the type and strength of immune responses elicited (created in https://BioRender.com ).
Mammography Equipment, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/large-scale+3d+reconstruction+engine+recap+photo/pm40374196-135-31-42?v=Siemens+AG
Average 90 stars, based on 1 article reviews
mammography equipment - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
3d printed ceramic structures  (BioMimetic Therapeutics)
90
BioMimetic Therapeutics 3d printed ceramic structures
The optimization strategies for enhancing LNP targeting and <t>endosomal</t> escape are summarized as follows: panel (A) illustrates organ‐selective delivery profiles of various LNP formulations. Conventional ionizable lipids with p K a values ranging from 6.2 to 6.5 (e.g., DLin‐DMA, MC3, SM‐102, ALC‐0315, and 113‐O12B) exhibit liver tropism. Permanently ionizable lipids (e.g., DOTAP, DDAB, EPC, and 306‐N16B) favor lung targeting, while anionic lipids (e.g., 18PA, 14PA, and 18BMP) and polymer modifications (e.g., APEs and Pi‐A10) are associated with spleen accumulation. Panel (B) depicts key mechanisms of endosomal escape that enhance both CD4⁺ and CD8⁺ T cell responses. Strategies include conjugating LNPs with antibodies or PEI polymers, inhibiting the interaction between LNPs and ANXA6, and employing ionizable lipids with unsaturated hydrophobic tails, which significantly improve endosomal escape efficiency and thereby enhance antigen expression and immune activation. Panel (C) shows that LNPs can bind to ApoE, which facilitates recognition by LDLRs on hepatic endothelial cells, contributing to hepatic accumulation—a typical feature of traditional LNPs. Panel (D) outlines injection sites for different administration routes (intramuscular, subcutaneous, intravenous, and intradermal), which influence how LNP‐based vaccines enter the body and determine the type and strength of immune responses elicited (created in https://BioRender.com ).
3d Printed Ceramic Structures, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/large-scale+3d+reconstruction+engine+recap+photo/pm39562544-195-5-16?v=BioMimetic+Therapeutics
Average 90 stars, based on 1 article reviews
3d printed ceramic structures - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
3-d thermal model  (ANSYS inc)
90
ANSYS inc 3-d thermal model
The optimization strategies for enhancing LNP targeting and <t>endosomal</t> escape are summarized as follows: panel (A) illustrates organ‐selective delivery profiles of various LNP formulations. Conventional ionizable lipids with p K a values ranging from 6.2 to 6.5 (e.g., DLin‐DMA, MC3, SM‐102, ALC‐0315, and 113‐O12B) exhibit liver tropism. Permanently ionizable lipids (e.g., DOTAP, DDAB, EPC, and 306‐N16B) favor lung targeting, while anionic lipids (e.g., 18PA, 14PA, and 18BMP) and polymer modifications (e.g., APEs and Pi‐A10) are associated with spleen accumulation. Panel (B) depicts key mechanisms of endosomal escape that enhance both CD4⁺ and CD8⁺ T cell responses. Strategies include conjugating LNPs with antibodies or PEI polymers, inhibiting the interaction between LNPs and ANXA6, and employing ionizable lipids with unsaturated hydrophobic tails, which significantly improve endosomal escape efficiency and thereby enhance antigen expression and immune activation. Panel (C) shows that LNPs can bind to ApoE, which facilitates recognition by LDLRs on hepatic endothelial cells, contributing to hepatic accumulation—a typical feature of traditional LNPs. Panel (D) outlines injection sites for different administration routes (intramuscular, subcutaneous, intravenous, and intradermal), which influence how LNP‐based vaccines enter the body and determine the type and strength of immune responses elicited (created in https://BioRender.com ).
3 D Thermal Model, supplied by ANSYS inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/large-scale+3d+reconstruction+engine+recap+photo/10__1109_slash_ted__2012__2224115-80-8-18?v=ANSYS+inc
Average 90 stars, based on 1 article reviews
3-d thermal model - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
large scale 3d intravascular imaging  (Light Labs Inc)
90
Light Labs Inc large scale 3d intravascular imaging
The optimization strategies for enhancing LNP targeting and <t>endosomal</t> escape are summarized as follows: panel (A) illustrates organ‐selective delivery profiles of various LNP formulations. Conventional ionizable lipids with p K a values ranging from 6.2 to 6.5 (e.g., DLin‐DMA, MC3, SM‐102, ALC‐0315, and 113‐O12B) exhibit liver tropism. Permanently ionizable lipids (e.g., DOTAP, DDAB, EPC, and 306‐N16B) favor lung targeting, while anionic lipids (e.g., 18PA, 14PA, and 18BMP) and polymer modifications (e.g., APEs and Pi‐A10) are associated with spleen accumulation. Panel (B) depicts key mechanisms of endosomal escape that enhance both CD4⁺ and CD8⁺ T cell responses. Strategies include conjugating LNPs with antibodies or PEI polymers, inhibiting the interaction between LNPs and ANXA6, and employing ionizable lipids with unsaturated hydrophobic tails, which significantly improve endosomal escape efficiency and thereby enhance antigen expression and immune activation. Panel (C) shows that LNPs can bind to ApoE, which facilitates recognition by LDLRs on hepatic endothelial cells, contributing to hepatic accumulation—a typical feature of traditional LNPs. Panel (D) outlines injection sites for different administration routes (intramuscular, subcutaneous, intravenous, and intradermal), which influence how LNP‐based vaccines enter the body and determine the type and strength of immune responses elicited (created in https://BioRender.com ).
Large Scale 3d Intravascular Imaging, supplied by Light Labs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/large-scale+3d+reconstruction+engine+recap+photo/10__1364_slash_ao__49__000d30-417-6-19?v=Light+Labs+Inc
Average 90 stars, based on 1 article reviews
large scale 3d intravascular imaging - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
software chipic3d  (Informa UK Limited)
90
Informa UK Limited software chipic3d
The optimization strategies for enhancing LNP targeting and <t>endosomal</t> escape are summarized as follows: panel (A) illustrates organ‐selective delivery profiles of various LNP formulations. Conventional ionizable lipids with p K a values ranging from 6.2 to 6.5 (e.g., DLin‐DMA, MC3, SM‐102, ALC‐0315, and 113‐O12B) exhibit liver tropism. Permanently ionizable lipids (e.g., DOTAP, DDAB, EPC, and 306‐N16B) favor lung targeting, while anionic lipids (e.g., 18PA, 14PA, and 18BMP) and polymer modifications (e.g., APEs and Pi‐A10) are associated with spleen accumulation. Panel (B) depicts key mechanisms of endosomal escape that enhance both CD4⁺ and CD8⁺ T cell responses. Strategies include conjugating LNPs with antibodies or PEI polymers, inhibiting the interaction between LNPs and ANXA6, and employing ionizable lipids with unsaturated hydrophobic tails, which significantly improve endosomal escape efficiency and thereby enhance antigen expression and immune activation. Panel (C) shows that LNPs can bind to ApoE, which facilitates recognition by LDLRs on hepatic endothelial cells, contributing to hepatic accumulation—a typical feature of traditional LNPs. Panel (D) outlines injection sites for different administration routes (intramuscular, subcutaneous, intravenous, and intradermal), which influence how LNP‐based vaccines enter the body and determine the type and strength of immune responses elicited (created in https://BioRender.com ).
Software Chipic3d, supplied by Informa UK Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/large-scale+3d+reconstruction+engine+recap+photo/10__1080_slash_10236198__2016__1235160-18-70-6?v=Informa+UK+Limited
Average 90 stars, based on 1 article reviews
software chipic3d - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


The optimization strategies for enhancing LNP targeting and endosomal escape are summarized as follows: panel (A) illustrates organ‐selective delivery profiles of various LNP formulations. Conventional ionizable lipids with p K a values ranging from 6.2 to 6.5 (e.g., DLin‐DMA, MC3, SM‐102, ALC‐0315, and 113‐O12B) exhibit liver tropism. Permanently ionizable lipids (e.g., DOTAP, DDAB, EPC, and 306‐N16B) favor lung targeting, while anionic lipids (e.g., 18PA, 14PA, and 18BMP) and polymer modifications (e.g., APEs and Pi‐A10) are associated with spleen accumulation. Panel (B) depicts key mechanisms of endosomal escape that enhance both CD4⁺ and CD8⁺ T cell responses. Strategies include conjugating LNPs with antibodies or PEI polymers, inhibiting the interaction between LNPs and ANXA6, and employing ionizable lipids with unsaturated hydrophobic tails, which significantly improve endosomal escape efficiency and thereby enhance antigen expression and immune activation. Panel (C) shows that LNPs can bind to ApoE, which facilitates recognition by LDLRs on hepatic endothelial cells, contributing to hepatic accumulation—a typical feature of traditional LNPs. Panel (D) outlines injection sites for different administration routes (intramuscular, subcutaneous, intravenous, and intradermal), which influence how LNP‐based vaccines enter the body and determine the type and strength of immune responses elicited (created in https://BioRender.com ).

Journal: MedComm

Article Title: Design Strategies for Novel Lipid Nanoparticle for mRNA Vaccine and Therapeutics: Current Understandings and Future Perspectives

doi: 10.1002/mco2.70414

Figure Lengend Snippet: The optimization strategies for enhancing LNP targeting and endosomal escape are summarized as follows: panel (A) illustrates organ‐selective delivery profiles of various LNP formulations. Conventional ionizable lipids with p K a values ranging from 6.2 to 6.5 (e.g., DLin‐DMA, MC3, SM‐102, ALC‐0315, and 113‐O12B) exhibit liver tropism. Permanently ionizable lipids (e.g., DOTAP, DDAB, EPC, and 306‐N16B) favor lung targeting, while anionic lipids (e.g., 18PA, 14PA, and 18BMP) and polymer modifications (e.g., APEs and Pi‐A10) are associated with spleen accumulation. Panel (B) depicts key mechanisms of endosomal escape that enhance both CD4⁺ and CD8⁺ T cell responses. Strategies include conjugating LNPs with antibodies or PEI polymers, inhibiting the interaction between LNPs and ANXA6, and employing ionizable lipids with unsaturated hydrophobic tails, which significantly improve endosomal escape efficiency and thereby enhance antigen expression and immune activation. Panel (C) shows that LNPs can bind to ApoE, which facilitates recognition by LDLRs on hepatic endothelial cells, contributing to hepatic accumulation—a typical feature of traditional LNPs. Panel (D) outlines injection sites for different administration routes (intramuscular, subcutaneous, intravenous, and intradermal), which influence how LNP‐based vaccines enter the body and determine the type and strength of immune responses elicited (created in https://BioRender.com ).

Article Snippet: Large‐scale endosomal rupture recruits galectins (e.g., Galectin‐8), which mediate inflammation cascades and facilitate autolysosomal degradation of damaged endosomes.

Techniques: Polymer, Expressing, Activation Assay, Injection, Vaccines